Sandoz Recalls Hydroxychloroquine Tablets Due to Illegible Logo
Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets because the logo on some tablets is illegible.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The issue is a cosmetic defect (illegible logo) with no reported injuries.
Plain-English summary
Sandoz Incorporated is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200 mg. The recall involves 25,830 bottles of the prescription medication, identified by Lot # BU3417 and an expiration date of 06/2014. The product was distributed nationwide.
The recall was initiated because the logo on some tablets is illegible. This issue falls under failed tablet specifications. The source text does not report any illnesses or injuries associated with this recall.
Consumers with this specific lot of medication should contact their healthcare provider or pharmacist for guidance on how to proceed. The recall is classified as Class III by the FDA, indicating that the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.
- Manufacturer
- Sandoz Incorporated
- Category
- Drug — Tablets
- Hazard
- Affected units
- 25,830
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: BU3417
- Exp 06/2014
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Sandoz Incorporated
See all →- ModerateSandoz Recalls Triamterene and Hydrochlorothiazide Tablets Due to Cross-Contamination
FDA (Drugs) · 2018-04-25
- ModerateSandoz Recalls Amitriptyline Hydrochloride Tablets Due to Cross-Contamination
FDA (Drugs) · 2017-07-12
- ModerateSandoz Recalls Nadolol Tablets Due to Failed Dissolution Test
FDA (Drugs) · 2017-01-04
- LowSandoz Recalls Fluoxetine Capsules Due to Illegible Logo
FDA (Drugs) · 2014-12-17
- SevereSandoz Recalls Alprazolam Tablets Due to Stainless Steel Particulates
FDA (Drugs) · 2014-08-06
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02